top
BRAINLIFE NEWSLETTER
Volume 3, Number 11 - 3 May 2004

Volume 3
Archive


Contents


Etiology & Pathogenesis
Integrative Medicine
Overall Management
Prognosis & Outcome
Treatment

Etiology & Pathogenesis


Fallon KB, Havlioglu N, Hamilton LH, Cheng TP, Carroll SL
Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line
J Neurooncol. 2004 Feb;66(3):273-84. 

Matsuo M, Yoshida N, Zaitsu M, Ishii K, Hamasaki Y
Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089
J Neurooncol. 2004 Feb;66(3):285-92. 


Integrative Medicine


Burzynski SR
The present state of antineoplaston research (1)
Integr Cancer Ther. 2004 Mar;3(1):47-58. 


Overall Management


Ars C, Duck L, Baurain JF, Moulin P, Duprez T, Machiels JP
Unusual metastatic features in a patient with concomitant malignant orbital melanoma and prostate carcinoma
J Neurooncol. 2004 Feb;66(3):361-3. 

Buhl R, Huang H, Hugo HH, Mehdorn HM
Ganglioneurocytoma of the third ventricle
J Neurooncol. 2004 Feb;66(3):341-4. 


Cenacchi G, Giangaspero F
Emerging tumor entities and variants of CNS neoplasms
J Neuropathol Exp Neurol. 2004 Mar;63(3):185-92. 

Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito F
Single brain metastases of carcinoid tumors
J Neurooncol. 2004 Feb;66(3):327-32. 


Prognosis & Outcome


Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):117-25. 

Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF, Gershenson DM, Sawaya R
Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome
J Neurooncol. 2004 Feb;66(3):313-25. 

Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF
Determinants of outcome in melanoma patients with cerebral metastases
J Clin Oncol. 2004 Apr 1;22(7):1293-300.


Treatment


Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A, Manzano H, Martin J, Rifa J
Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider
J Neurooncol. 2004 Feb;66(3):345-50. 

Alba A. Brandes, Umberto Basso, Michele Reni, Francesca Vastola, Alicia Tosoni, Giovanna Cavallo, Luciano Scopece, Andres J. Ferreri, Maria G. Panucci, Silvio Monfardini, Mario Ermani
First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia
Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp. 1598-1604. 

Parker RJ, Fruehauf JP, Mehta R, Filka E, Cloughesy T
A prospective blinded study of the predictive value of an extreme drug resistance assay in patients receiving CPT-11 for recurrent glioma
J Neurooncol. 2004 Feb;66(3):365-75. 

Sharma RR, Singh DP, Pathak A, Khandelwal N, Sehgal CM, Kapoor R, Ghoshal S, Patel FD, Sharma SC
Local control of high-grade gliomas with limited volume irradiation versus whole brain irradiation
Neurol India. 2003 Dec;51(4):512-7. 

Swennen MH, Bromberg JE, Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ
Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma
J Neurooncol. 2004 Feb;66(3):333-9. 

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP